BioNTech said testing of two dosages of its BNT162b1 drug on 24 healthy volunteers showed that after 28 days they had developed higher levels of COVID-19 antibodies than typically seen in infected people
The aviation industry has been hammered by the travel restrictions imposed to contain the outbreak, with firms worldwide still uncertain when they will be able to get grounded planes back into the air.